Jessica A. Beach

305 Grattan Street
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.

Phenotypic Consequences of SLC25A40-ABCB1 Fusions beyond Drug Resistance in High-Grade Serous Ovarian Cancer.

Journal: Cancers
Published: September 28, 2021

HOXB13 controls cell state through super-enhancers.

HOXB13 controls cell state through super-enhancers.

Journal: Experimental cell research
Published: April 02, 2020

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML models.

Journal: Blood advances
Published: January 31, 2020

Going to extremes: determinants of extraordinary response and survival in patients with cancer.

Going to extremes: determinants of extraordinary response and survival in patients with cancer.

Journal: Nature reviews. Cancer
Published: May 12, 2019

Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer.

Mechanisms of Drug Resistance in High-Grade Serous Ovarian Cancer.

Journal: Hematology/oncology clinics of North America
Published: November 05, 2018

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer.

Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer.

Journal: Nature communications
Published: October 22, 2018

Commentary on "Epithelial-to-Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer".

Commentary on "Epithelial-to-Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer".

Journal: Cancer research
Published: November 04, 2016

Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.

Sphingosine kinase 1 is required for TGF-β mediated fibroblastto- myofibroblast differentiation in ovarian cancer.

Journal: Oncotarget
Published: August 18, 2015

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation.

Suboptimal cytoreduction in ovarian carcinoma is associated with molecular pathways characteristic of increased stromal activation.

Journal: Gynecologic oncology
Published: July 12, 2015

ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.

ADAM12 is a prognostic factor associated with an aggressive molecular subtype of high-grade serous ovarian carcinoma.

Journal: Carcinogenesis
Published: February 05, 2015

Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells.

Correlation of glucocorticoid-mediated E4BP4 upregulation with altered expression of pro- and anti-apoptotic genes in CEM human lymphoblastic leukemia cells.

Journal: Biochemical and biophysical research communications
Published: July 17, 2014

Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.

Succinate dehydrogenase inhibition leads to epithelial-mesenchymal transition and reprogrammed carbon metabolism.

Journal: Cancer & metabolism
Published: May 20, 2014
Showing 1-12 of 15

Last Updated: 09/26/2026